Search Results - "Technology Assessment, Biomedical methods"
-
1
Authors: et al.
Source: Ferizovic, N, Plackett, R, Clarke, C S, Hunter, R & Freemantle, N 2025, 'Value attributes of advanced therapy medicinal products : a documentary analysis of comments received from stakeholders during reimbursement decisions to England's National Institute of Health and Care Excellence', Expert Review of Pharmacoeconomics & Outcomes Research, vol. 25, no. 4, pp. 605-621. https://doi.org/10.1080/14737167.2025.2455405
Subject Terms: Reimbursement Mechanisms, Technology Assessment, Biomedical, England, Stakeholder Participation, Technology Assessment, Biomedical/methods, Delivery of Health Care/economics, Decision Making, Humans, Delivery of Health Care
File Description: application/pdf
-
2
Authors: et al.
Contributors: et al.
Source: Value in Health. 25:390-399
Subject Terms: Technology Assessment, Biomedical, Technology Assessment, Biomedical/methods, Cost-Benefit Analysis, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Cost-Benefit Analysis/methods, Journal Article, SDG 13 - Climate Action, Humans, health technology assessment, Therapies, Investigational/economics, Retrospective Studies, advanced therapies, Health Policy, Therapies, Investigational, Public Health, Environmental and Occupational Health, Uncertainty, advanced therapy medicinal products, Insurance, Health, Reimbursement/economics, gene therapy, 3. Good health, Europe, Insurance, Health, Reimbursement, cell therapy, 0305 other medical science, Ethical Analysis
File Description: application/pdf
Access URL: http://www.valueinhealthjournal.com/article/S1098301521017538/pdf
https://pubmed.ncbi.nlm.nih.gov/35227451
https://eprints.gla.ac.uk/260366/1/260366.pdf
https://dspace.library.uu.nl/handle/1874/446974
https://dspace.library.uu.nl/handle/1874/417731
https://dspace.library.uu.nl/handle/1874/419056 -
3
Authors: et al.
Source: Capkun, G, Corry, S, Dowling, O, Asad Zadeh Vosta Kolaei, F, Takyar, S, Furtado, C, Jónsson, P, Kleinermans, D, Lambert, L, Schiel, A & Facey, K 2022, ' Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making? ', International journal of technology assessment in health care, vol. 38, no. 1, pp. e79 . https://doi.org/10.1017/S0266462322000605
Subject Terms: 03 medical and health sciences, Technology Assessment, Biomedical, 0302 clinical medicine, Technology Assessment, Biomedical/methods, Reproducibility of Results, Trust, 0305 other medical science, 3. Good health
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/36321447
https://hdl.handle.net/20.500.11820/723473b5-6889-4b77-a9e9-aaccf0109bd9
https://www.pure.ed.ac.uk/ws/files/308323564/Can_we_use_existing_guidance_to_support_the_development_of_robust_real_world_evidence_for_health_technology_assessment_payer_decision_making.pdf -
4
Authors: et al.
Source: Value in Health, 20, 10, pp. 1411-1419
Degeling, K, Schivo, S, Mehra, N, Koffijberg, H, Langerak, R, de Bono, J S & IJzerman, M J 2017, 'Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions : An Illustration for Metastatic Castration-Resistant Prostate Cancer', Value in Health, vol. 20, no. 10, pp. 1411-1419. https://doi.org/10.1016/j.jval.2017.05.024Subject Terms: Castration-Resistant/pathology, Male, Technology Assessment, Biomedical, Time Factors, Technology Assessment, Biomedical/methods, Clinical Decision-Making, Radionuclide Imaging/methods, UT-Hybrid-D, Economic, Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences, Discrete event simulation, Advanced modeling methods, Decision Support Techniques, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Models, Technology Assessment, Tumor/metabolism, Biomarkers, Tumor, Humans, Computer Simulation, Precision Medicine, Medical Oncology - Radboud University Medical Center, Timed automata, Radionuclide Imaging, Personalized treatment decisions, Prostatic Neoplasms, Castration-Resistant/pathology, Health economic modeling, Prostatic Neoplasms, Precision Medicine/methods, Prostate-Specific Antigen, 3. Good health, Prostate-Specific Antigen/metabolism, Prostatic Neoplasms, Castration-Resistant, Models, Economic, Biomarkers, Tumor/metabolism, Biomedical/methods, Biomarkers
Access URL: http://www.valueinhealthjournal.com/article/S1098301517302772/pdf
https://pubmed.ncbi.nlm.nih.gov/29241901
https://research.utwente.nl/en/publications/9e0e0fd6-f772-4883-8527-2a3e6787a3db
https://doi.org/10.1016/j.jval.2017.05.024
https://www.ncbi.nlm.nih.gov/pubmed/29241901
https://www.sciencedirect.com/science/article/pii/S1098301517302772
https://repository.ubn.ru.nl/handle/2066/182451
https://www.narcis.nl/publication/RecordID/oai%3Aresearch.ou.nl%3Apublications%2Fd5950b0b-d29e-40af-a2fc-c65d5c2eef40
https://core.ac.uk/display/154385668
https://findanexpert.unimelb.edu.au/scholarlywork/1326499-comparison-of-timed-automata-with-discrete-event-simulation-for-modeling-of-biomarker-based-treatment-decisions--an-illustration-for-metastatic-castration-resistant-prostate-cancer
https://hdl.handle.net/2066/182451 -
5
Authors: et al.
Contributors: et al.
Source: Kristensen, F B, Lampe, K, Wild, C, Cerbo, M, Goettsch, W & Becla, L 2017, ' The HTA Core Model ® —10 Years of Developing an International Framework to Share Multidimensional Value Assessment ', Value in Health, vol. 20, no. 2, pp. 244-250 . https://doi.org/10.1016/j.jval.2016.12.010
Subject Terms: Technology Assessment, Biomedical, Information Dissemination, Technology Assessment, Biomedical/methods, International Cooperation, Decision Making, methodology, Models, Theoretical, health care, decision making, 3. Good health, Europe, 03 medical and health sciences, 0302 clinical medicine, Theoretical, Models, Technology Assessment, Taverne, health technology assessment, Biomedical/methods, 0305 other medical science
File Description: application/pdf
Access URL: http://www.valueinhealthjournal.com/article/S1098301516342206/pdf
https://pubmed.ncbi.nlm.nih.gov/28237203
https://research-portal.uu.nl/en/publications/2dd7da4d-9940-4fff-b570-ddd711c580fe
https://doi.org/10.1016/j.jval.2016.12.010
https://www.ncbi.nlm.nih.gov/pubmed/28237203
http://findresearcher.sdu.dk/portal/da/publications/the-hta-core-model10-years-of-developing-an-international-framework-to-share-multidimensional-value-assessment (4ef322c4-c719-455c-9e1a-b5bd53c8d537).html
https://www.sciencedirect.com/science/article/pii/S1098301516342206
http://europepmc.org/abstract/MED/28237203
https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=201702233216935949
https://www.sciencedirect.com/science/article/abs/pii/S1098301516342206
https://findresearcher.sdu.dk:8443/ws/files/144584109/The_HTA_Core_Model.pdf
https://dspace.library.uu.nl/handle/1874/428449 -
6
Authors: et al.
Source: Tidsskrift for Den Norske Laegeforening. 138(9):815
-
7
Authors:
Contributors:
Source: Health Policy. 65:217-226
Subject Terms: Medicine(all), Evidence-based medicine, Evidence-Based Medicine, Technology Assessment, Biomedical, Technology Assessment, Biomedical/methods, Health Policy, Social Sciences, Health policy, Health Services Research/methods, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, EMC NIHES-05-63-01 Management, policy making, Humans, Health Services Research, Policy Making, 0305 other medical science, social sciences, qualitative research, Qualitative Research
Access URL: https://pubmed.ncbi.nlm.nih.gov/12941490
https://pure.eur.nl/en/publications/0c9427bd-9f80-4434-99b5-03086bde2140
https://www.sciencedirect.com/science/article/pii/S0168851002002099
https://ideas.repec.org/a/eee/hepoli/v65y2003i3p217-226.html
https://www.ncbi.nlm.nih.gov/pubmed/12941490
https://researchportal.vub.be/en/publications/qualitative-evidence-and-health-technology -assessment
https://hdl.handle.net/20.500.14017/58a1f7fa-f4f8-4b73-b8a3-7988ea7bf291
https://biblio.vub.ac.be/vubir/(58a1f7fa-f4f8-4b73-b8a3-7988ea7bf291).html
https://doi.org/10.1016/s0168-8510(02)00209-9 -
8
Authors: et al.
Source: Norsk Epidemiologi. 23(2):171
-
9
Authors: et al.
Source: Norsk Epidemiologi. 23(2):165
-
10
-
11
Authors: et al.
Source: Tandläkartidningen. 104(10):60
-
12
Authors: et al.
Source: Michael Quarterly. 9(2):109
-
13
Authors:
Source: Michael Quarterly. 9(2):165
-
14
Authors: et al.
Source: Michael Quarterly. 9(2):183
-
15
-
16
-
17
-
18
Authors: et al.
Source: Läkartidningen. 107(29-31):1780
-
19
Authors: Hedlund, F
Source: Läkemedelsvärlden. 112(3):24
-
20
Authors: et al.
Source: Tidsskrift for Den Norske Laegeforening. 124(20):2640
Nájsť tento článok vo Web of Science
Full Text Finder